Welcome to the OvaScience Securities Litigation Website

This website has been established to provide general information related to the proposed settlement of the case known as Dahhan v. OvaScience, Inc., et al., Civil Action No. 1:17-cv-10511-IT (the "Action"), pending before the United States District Court for the District of Massachusetts (the "Court"). The capitalized terms used on this website, and not otherwise defined, shall have the same meanings ascribed to them in the Stipulation and Agreement of Settlement dated March 4, 2022 (the "Stipulation"), which can be found and downloaded by clicking on the Case Documents tab above. Your rights may be affected by the Settlement if you purchased or otherwise acquired OvaScience, Inc. ("OvaScience" or the "Company") common stock between December 17, 2014 and September 28, 2015, inclusive (the “Class Period”).

The entity that leads the Litigation, Reedman Family Investments LLC, is referred to as the “Class Representative” or “Lead Plaintiff.” The entities and individuals, OvaScience, Longwood Fund, L.P., Longwood Fund, GP, LLC (“Longwood Funds”), and Michelle Dipp (“Dipp”), Jeffrey E. Young (“Young”), and Richard Aldrich (“Aldrich”) (“Individual Defendants”). OvaScience, Dipp, and Young are collectively referred to as the “OvaScience Defendants.” The Longwood Funds and Aldrich are the “Longwood Defendants.” Collectively, the Individual Defendants, the OvaScience Defendants, and the Longwood Defendants, being sued are the “Defendants.”

The law firm of Robbins Geller Rudman & Dowd LLP (“Lead Counsel”) represent Class Members. Class Members will not be charged for these lawyers. They will be paid from the Settlement Fund to the extent the Court approves their application for fees and expenses.

WHAT IS THIS LAWSUIT ABOUT?

As more fully described in the Notice of (I) Proposed Settlement and Plan of Allocation; (II) Settlement Hearing; and (III) Motion for Attorneys’ Fees and Litigation Expenses(the "Settlement Notice"), on August 25, 2017, Lead Plaintiff filed an amended complaint in the Action, the Amended Class Action Complaint (the “Complaint”). The Complaint asserts claims against OvaScience and Dipp under Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, and against Dipp and Young under Section 20(a) of the Exchange Act. Among other things, the Complaint alleges that, during the Class Period, the OvaScience Defendants knowingly or recklessly misrepresented and concealed material facts regarding the efficacy and commercial viability of AUGMENT. More specifically, the Complaint alleges that throughout the Class Period, the OvaScience Defendants made numerous public statements that led investors to believe that AUGMENT worked, and that there was significant demand from patients, which caused OvaScience’s common stock to allegedly trade at artificially inflated prices during the Class Period. The Complaint further alleges that the price of OvaScience stock declined when the true facts concerning the OvaScience Defendants’ alleged misrepresentations and omissions were revealed, resulting in financial losses to those who purchased or acquired OvaScience common stock during the Class Period at the inflated prices.

WHAT DOES THE SETTLEMENT PROVIDE?

Pursuant to the Settlement, Defendants have agreed to pay or caused to be paid a total of $15,000,000 in cash (the “Settlement Amount”). The Settlement Amount will be deposited into an escrow account. The Settlement Amount plus any interest earned thereon is referred to as the “Settlement Fund.” If the Settlement is approved by the Court and the Effective Date occurs, the Net Settlement Fund will be distributed to Class Members who submit valid Claim Forms, in accordance with the proposed Plan of Allocation or such other plan of allocation as the Court may approve.

ADDITIONAL INFORMATION

Although the information in this website is intended to assist you, it does not replace the information contained in the Settlement Notice and Stipulation, both of which can be found and downloaded by clicking on the Case Documents tab above. We recommend that you read the Notice and other relevant case documents carefully.

YOUR LEGAL RIGHTS AND OPTIONS IN THIS SETTLEMENT

IMPORTANT DATES AND DEADLINES